Insider track record Other Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Tony Wood. Officer active across 1 company, notably GSK plc. Aggregated, 45 disclosures have been recorded. History available since 16 October 2023. The latest transaction was filed on 9 July 2026 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.
Companies and markets linked to Tony Wood Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 45 total
● Chief Scientific Officer · Executives · 9 Jul 2026 · GSK plc 2,273.327 shares @ £19.6297 0.0058% mcap 0.4% of flow ISIN ISIN GB00BN7SWP63RNS:9668630-10 ● Chief Scientific Officer · Executives · 10 Jul 2026 · GSK plc 1,015 shares @ £19.595 0.0026% mcap 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:9668630-23 ● Chief Scientific Officer · Executives · 9 Jul 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:0920c70b-f075-4c99-aba0-46720a29730a-10 ● Chief Scientific Officer · Executives · 14 Apr 2026 · GSK plc 965 shares @ £21.67 0.0000% mcap 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-9 ● Chief Scientific Officer · Executives · 9 Apr 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-14 ● Chief Scientific Officer · Executives · 18 Feb 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:342d95ec-4ba6-48b0-a108-3953a4b5fc9c ● Chief Scientific Officer · Executives · 13 Feb 2026 · GSK plc 219,851 shares 0
ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-24 ● Chief Scientific Officer · Executives · 13 Feb 2026 · GSK plc 103,330 shares @ £21.6002 19.5% of flow ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-25 ● Chief Scientific Officer · Executives · 12 Feb 2026 · GSK plc 25,915 shares @ £21.50 4.9% of flow ISIN ISIN GB00BN7SWP63RNS:6207777f-2477-470b-868f-21f92714189a-9 ● Chief Scientific Officer · Executives · 12 Feb 2026 · GSK plc 247,138 shares @ £21.50 46.4% of flow ISIN ISIN GB00BN7SWP63RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-13 ● Chief Scientific Officer · Executives · 9 Feb 2026 · GSK plc 21,176 shares 0
ISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-16 ● Chief Scientific Officer · Executives · 9 Feb 2026 · GSK plc 9,978 shares @ £22.1186 1.9% of flow ISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-17 ● Chief Scientific Officer · Executives · 8 Jan 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-21 ● Chief Scientific Officer · Executives · 9 Jan 2026 · GSK plc 934 shares @ £18.91 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-33 ● Chief Scientific Officer · Executives · 10 Oct 2025 · GSK plc 1,067 shares @ £16.40 0.6% of flow ISIN ISIN GB00BN7SWP63RNS:5862277-11 ● Chief Scientific Officer · Executives · 9 Oct 2025 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:5859068-23 ● Chief Scientific Officer · Executives · 11 Jul 2025 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:5739159-14 ● Chief Scientific Officer · Executives · 10 Jul 2025 · GSK plc 1,190 shares @ £14.545 0.6% of flow ISIN ISIN GB00BN7SWP63RNS:5737340-30 ● Chief Scientific Officer · Executives · 16 Apr 2025 · GSK plc 1,340 shares @ £12.75 0.6% of flow ISIN ISIN GB00BN7SWP63RNS:5622701-11 ● Chief Scientific Officer · Executives · 10 Apr 2025 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:5617047-19 ● Chief Scientific Officer · Executives · 17 Feb 2025 · GSK plc 27,146 shares @ £14.35 13.3% of flow ISIN ISIN GB00BN7SWP63RNS:5546650-11 ● Chief Scientific Officer · Executives · 18 Feb 2025 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:5546644 ● Chief Scientific Officer · Executives · 18 Feb 2025 · GSK plc 97,444 shares 0
ISIN ISIN GB00BN7SWP63RNS:5546637-19 ● Chief Scientific Officer · Executives · 18 Feb 2025 · GSK plc 45,799 shares @ £14.2531 22.4% of flow ISIN ISIN GB00BN7SWP63RNS:5546637-20 ● Chief Scientific Officer · Executives · 17 Feb 2025 · GSK plc 24,638 shares @ £14.1829 11.9% of flow ISIN ISIN GB00BN7SWP63RNS:5546608-0 25 of 45 declarations
Load more (20 remaining) About Tony Wood Tony Wood is an insider at GSK plc, where he is Chief Scientific Officer. He has 44 filings in total, and across the sampled recent filings, buys amount to EUR 52358 and sells to EUR 4047823, over the period from 2023-10-18 to 2026-07-15. The modal transaction nature is Vesting.